Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eighteen analysts that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $45.06.
A number of research analysts have issued reports on BBWI shares. Barclays reduced their price objective on Bath & Body Works from $43.00 to $38.00 and set an “equal weight” rating for the company in a research note on Monday, March 3rd. Cowen restated a “buy” rating on shares of Bath & Body Works in a report on Thursday, February 27th. Piper Sandler boosted their target price on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. Telsey Advisory Group restated an “outperform” rating and set a $43.00 price target on shares of Bath & Body Works in a research note on Thursday, February 27th. Finally, TD Cowen lifted their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a report on Thursday, December 12th.
View Our Latest Research Report on BBWI
Institutional Trading of Bath & Body Works
Bath & Body Works Price Performance
Shares of BBWI stock opened at $27.11 on Friday. The firm has a 50-day moving average of $34.45 and a 200-day moving average of $34.10. Bath & Body Works has a one year low of $25.41 and a one year high of $52.99. The company has a market cap of $5.81 billion, a P/E ratio of 6.61, a P/E/G ratio of 0.92 and a beta of 1.89.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, beating the consensus estimate of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion. As a group, research analysts expect that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.
Bath & Body Works Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.95%. Bath & Body Works’s dividend payout ratio (DPR) is currently 21.98%.
Bath & Body Works announced that its Board of Directors has initiated a share buyback program on Thursday, February 27th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 6.4% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its stock is undervalued.
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also
- Five stocks we like better than Bath & Body Works
- How to Evaluate a Stock Before Buying
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- What does consumer price index measure?
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.